Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
August 21, 2018
Patent Application Number
15034992
Date Filed
November 5, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided herein are anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
